QA: BALCHEM CORP in us_medicinal_products/2019

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000009326_2020_BALCHEM_CORP.pdf

Logs

info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0000009326, BALCHEM CORP

  xvar xval
0 LiabilitiesNoncurrent 4,827,000
1 LiabilitiesCurrent 148,689,000
2 remainder_Liabilities 258,499,000
3 AssetsCurrent 254,946,000
4 AssetsNoncurrent 15,955,000
5 PropertyPlantAndEquipmentNet 216,859,000
6 Goodwill 667,922,000
7 remainder_Assets 0
8 GeneralAndAdministrativeExpense 529,775,000
9 ResearchAndDevelopmentExpense 11,377,000
10 remainder_Expenses 16,807,000
11 remainder_Revenues 643,705,000
12 remainder_NetIncome -6,075,000
13 remainder_ComprehensiveNetIncome -1,962,000
  yvar yval
0 Liabilities 412,015,000
1 Assets 1,155,682,000
2 Expenses 557,959,000
3 Revenues 643,705,000
4 StockholdersEquity 743,667,000
5 NetIncome 79,671,000
6 ComprehensiveNetIncome 78,690,000
7 BaseVar 1,388,699,000
8 EconomicCapitalRatio 0.907

Edgar->Model Mapping

Feature Distribution

Change over Time